Specialization
T2DM, diabetic kidney disease, gut microbiota, sodium homeostasis
Focus of research
T2DM, diabetic kidney disease, gut microbiota, sodium homeostasis
-
Effects of dapagliflozin on sodium excretion, blood pressure and volume status in patients with type 2 diabetes and/or chronic kidney disease: The DAPASALT trial
Beernink, J. M., Jongs, N., Mosterd, C. M., Scholtes, R. A., Caldwell-McGee, A., Casillas, D., Driscoll, L., Greasley, P. J., Karlsson, C., Hammarstedt, A., Sridhar, V. S., Muskiet, M. H. A., Laverman, G. D., Cherney, D. Z. I., Bjornstad, P., van Raalte, D. H. & Heerspink, H. J. L., Aug 2025, In: Diabetes, Obesity and Metabolism. 27, 8, p. 4415-4426 12 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Plasma and Urine Metabolites Associated With Nondiabetic Chronic Kidney Disease: The HELIUS Study
Mosterd, C. M., Verhaar, B. J. H., van den Born, B.-J. H., Nieuwdorp, M. & van Raalte, D. H., 1 Jul 2025, In: Kidney Medicine. 7, 7, 101009.Research output: Contribution to journal › Article* › Academic › peer-review
-
Mechanistic evaluation of ertugliflozin in patients with type 2 diabetes and heart failure
Lytvyn, Y., Scholtes, R. A., Boorsma, E. M., Sridhar, V. S., Kugathasan, L., Liu, H., Lovblom, L. E., Handoko, L., Mosterd, C. M., Floras, J. S., Burns, K., Osuntokun, T., Voors, A., van Raalte, D. H., Heerspink, H. J. L. & Cherney, D. Z. I., 1 Apr 2025, In: Physiological reports. 13, 7, e70275.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications